West Announces First-Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/11/2026
- Wall Street ends down as US-Iran peace optimism fades
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
UPDATE: West Pharma (WST) Q1 EPS Tops Views; Reaffirms Guidance
April 27, 2017 7:03 AM EDT(Updated - April 27, 2017 9:16 AM EDT)
(Update corrects Q1 EPS)
West Pharma (NYSE: WST) reported Q1 EPS of $0.81, better than the analyst estimate of $0.55. First-quarter 2017 reported-diluted EPS includes the impact of a tax benefit of $0.21. Revenue for the quarter came in at $387.7 million... More
